Omega Medical Imaging, LLC

Omega Medical Imaging, LLC manufactures AI-enabled interventional imaging systems designed to reduce radiation exposure in cardiology and gastroenterology procedures. The company's core technology platform, FluoroShield™, functions as a secondary collimator using artificial intelligence to establish a Region of Interest (ROI), reducing unnecessary radiation to peripheral anatomy while maintaining image quality. Products include Soteria.AI for cardiac catheterization labs and E-View.AI for endoscopy systems, both incorporating real-time AI image guidance. The company reports radiation dose reductions up to 84% compared to conventional fluoroscopy. Omega Medical Imaging is FDA-approved for their AI-enabled X-ray systems and manufactures equipment in the United States. The company serves interventional cardiologists, gastroenterologists, and hospital interventional labs. Product lines include cardiac systems (fluoroscopy for catheterization procedures), endoscopy systems (GI/ERCP), electrophysiology labs, and surgical displays. The company emphasizes workflow integration, enabling seamless AI detection without interrupting clinical procedures. Additionally featured are TruBlock™ technology for ROI concentration and advanced image processing for both cine and fluoroscopy modes.